Empyrean Capital Partners, LP Bausch & Lomb Corp Transaction History
Empyrean Capital Partners, LP
- $2.01 Billion
- Q3 2024
A detailed history of Empyrean Capital Partners, LP transactions in Bausch & Lomb Corp stock. As of the latest transaction made, Empyrean Capital Partners, LP holds 1,238,000 shares of BLCO stock, worth $23.2 Million. This represents 1.19% of its overall portfolio holdings.
Number of Shares
1,238,000
Previous 385,000
221.56%
Holding current value
$23.2 Million
Previous $5.59 Million
327.21%
% of portfolio
1.19%
Previous 0.4%
Shares
2 transactions
Others Institutions Holding BLCO
# of Institutions
118Shares Held
37.8MCall Options Held
116KPut Options Held
299K-
Maple Rock Capital Partners Inc. Toronto, A63.62MShares$67.9 Million2.04% of portfolio
-
Icahn Carl C Sunny Isles Beach, FL3.5MShares$65.7 Million0.69% of portfolio
-
Goldentree Asset Management LP New York, NY3.36MShares$62.9 Million5.89% of portfolio
-
Alberta Investment Management Corp Edmonton, A02.21MShares$41.5 Million0.42% of portfolio
-
River Road Asset Management, LLC2.02MShares$37.9 Million0.54% of portfolio
About Bausch & Lomb Corp
- Ticker BLCO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 350,000,000
- Market Cap $6.57B
- Description
- Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replace...